DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy-Reference-Cited by-同舟云学术

DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy

Published:2016-05 Issue: Volume:229 Page:154-162
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Camacho Kathryn M.,Menegatti Stefano,Vogus Douglas R.,Pusuluri Anusha,Fuchs Zoë,Jarvis Maria,Zakrewsky Michael,Evans Michael A.,Chen Renwei,Mitragotri Samir

Funder

University of California, Santa Barbara

University of California, Office of the President

NSF

NIH

NSF Graduate Research Fellowship

UCSB Duncan and Suzanne Mellichamp cluster

Department of Defense CDMRP Breast Cancer Research Program

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference88 articles.

1. Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma;Lyass;Cancer,2000

2. Pegylated liposomal doxorubicin (Doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500mg/m2;Safra;Ann. Oncol.,2000

3. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation;Muggia;J. Clin. Oncol.,1997

4. Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL®/CAELYX®) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group;Judson;Eur. J. Cancer,2001

5. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYXTM/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer;O'Brien;Ann. Oncol.,2004

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. pH-Sensitive Nanodrug Self-Assembled from Aliphatic 5-Fluorouracil Derivative and Doxorubicin for Synergistic Cancer Therapy;ACS Applied Nano Materials;2024-04-25

2. Liposomes and their historical use for cancer applications;Cancer Therapy;2024

3. Current trends in the development of liposomes for chemotherapeutic drug delivery;Journal of Drug Delivery Science and Technology;2023-09

4. HDACIs and TKIs combinations and their liposomal delivery for cancer treatment;Journal of Controlled Release;2023-06

5. Dual Drug-Loaded Nanoliposomes Encapsulating Curcumin and 5-Fluorouracil with Advanced Medicinal Applications: Self-Monitoring and Antitumor Therapy;Molecules;2023-05-25